Oncoinvent pulls in about $25 mln
Oslo, Norway-based Oncoinvent, a developer of cancer treatments, has raised about $25 million. The investors included Geveran Trading Co. Ltd, Canica AS, CGS Holding AS, Helene Sundt AS and Must Invest AS.
13 February 2017•1 min read
